Cholera Vaccine (Oral Route) Market Report

Global Cholera Vaccine (Oral Route) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 23, 2022
  • PAGES：135
  • REPORT CODE：GMM763778
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Cholera Vaccine (Oral Route) market report explains the definition, types, applications, major countries, and major players of the Cholera Vaccine (Oral Route) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Valneva

    • EuBiologics

    • PaxVax

    • Sanofi

    By Type:

    • Shanchol

    • Dukoral

    • Vaxchora

    • Others

    By End-User:

    • Hospital

    • Research & Academic Laboratories

    • Pharmaceutical & Biotechnology Companies

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Cholera Vaccine (Oral Route) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Cholera Vaccine (Oral Route) Outlook to 2028- Original Forecasts

    • 2.2 Cholera Vaccine (Oral Route) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Cholera Vaccine (Oral Route) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Cholera Vaccine (Oral Route) Market- Recent Developments

    • 6.1 Cholera Vaccine (Oral Route) Market News and Developments

    • 6.2 Cholera Vaccine (Oral Route) Market Deals Landscape

    7 Cholera Vaccine (Oral Route) Raw Materials and Cost Structure Analysis

    • 7.1 Cholera Vaccine (Oral Route) Key Raw Materials

    • 7.2 Cholera Vaccine (Oral Route) Price Trend of Key Raw Materials

    • 7.3 Cholera Vaccine (Oral Route) Key Suppliers of Raw Materials

    • 7.4 Cholera Vaccine (Oral Route) Market Concentration Rate of Raw Materials

    • 7.5 Cholera Vaccine (Oral Route) Cost Structure Analysis

      • 7.5.1 Cholera Vaccine (Oral Route) Raw Materials Analysis

      • 7.5.2 Cholera Vaccine (Oral Route) Labor Cost Analysis

      • 7.5.3 Cholera Vaccine (Oral Route) Manufacturing Expenses Analysis

    8 Global Cholera Vaccine (Oral Route) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Cholera Vaccine (Oral Route) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Cholera Vaccine (Oral Route) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Cholera Vaccine (Oral Route) Market Outlook by Types and Applications to 2022

    • 9.1 Global Cholera Vaccine (Oral Route) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Shanchol Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Dukoral Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Vaxchora Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global $Cholera Vaccine (Oral Route) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research & Academic Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Cholera Vaccine (Oral Route) Market Analysis and Outlook till 2022

    • 10.1 Global Cholera Vaccine (Oral Route) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.2.2 Canada Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.2.3 Mexico Cholera Vaccine (Oral Route) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.2 UK Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.3 Spain Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.4 Belgium Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.5 France Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.6 Italy Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.7 Denmark Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.8 Finland Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.9 Norway Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.10 Sweden Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.11 Poland Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.12 Russia Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.3.13 Turkey Cholera Vaccine (Oral Route) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.2 Japan Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.3 India Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.4 South Korea Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.5 Pakistan Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.6 Bangladesh Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.7 Indonesia Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.8 Thailand Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.9 Singapore Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.10 Malaysia Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.11 Philippines Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.4.12 Vietnam Cholera Vaccine (Oral Route) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.5.2 Colombia Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.5.3 Chile Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.5.4 Argentina Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.5.5 Venezuela Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.5.6 Peru Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.5.8 Ecuador Cholera Vaccine (Oral Route) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.6.2 Kuwait Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.6.3 Oman Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.6.4 Qatar Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Cholera Vaccine (Oral Route) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.7.2 South Africa Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.7.3 Egypt Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.7.4 Algeria Cholera Vaccine (Oral Route) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Cholera Vaccine (Oral Route) Consumption (2017-2022)

      • 10.8.2 New Zealand Cholera Vaccine (Oral Route) Consumption (2017-2022)

    11 Global Cholera Vaccine (Oral Route) Competitive Analysis

    • 11.1 Valneva

      • 11.1.1 Valneva Company Details

      • 11.1.2 Valneva Cholera Vaccine (Oral Route) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Valneva Cholera Vaccine (Oral Route) Main Business and Markets Served

      • 11.1.4 Valneva Cholera Vaccine (Oral Route) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 EuBiologics

      • 11.2.1 EuBiologics Company Details

      • 11.2.2 EuBiologics Cholera Vaccine (Oral Route) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 EuBiologics Cholera Vaccine (Oral Route) Main Business and Markets Served

      • 11.2.4 EuBiologics Cholera Vaccine (Oral Route) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 PaxVax

      • 11.3.1 PaxVax Company Details

      • 11.3.2 PaxVax Cholera Vaccine (Oral Route) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 PaxVax Cholera Vaccine (Oral Route) Main Business and Markets Served

      • 11.3.4 PaxVax Cholera Vaccine (Oral Route) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Sanofi

      • 11.4.1 Sanofi Company Details

      • 11.4.2 Sanofi Cholera Vaccine (Oral Route) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Sanofi Cholera Vaccine (Oral Route) Main Business and Markets Served

      • 11.4.4 Sanofi Cholera Vaccine (Oral Route) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    12 Global Cholera Vaccine (Oral Route) Market Outlook by Types and Applications to 2028

    • 12.1 Global Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Shanchol Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Dukoral Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Vaxchora Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Research & Academic Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Cholera Vaccine (Oral Route) Market Analysis and Outlook to 2028

    • 13.1 Global Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.2 UK Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.5 France Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.3 India Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Cholera Vaccine (Oral Route) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Cholera Vaccine (Oral Route)

    • Figure of Cholera Vaccine (Oral Route) Picture

    • Table Global Cholera Vaccine (Oral Route) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Cholera Vaccine (Oral Route) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Shanchol Consumption and Growth Rate (2017-2022)

    • Figure Global Dukoral Consumption and Growth Rate (2017-2022)

    • Figure Global Vaxchora Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Research & Academic Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Cholera Vaccine (Oral Route) Consumption by Country (2017-2022)

    • Table North America Cholera Vaccine (Oral Route) Consumption by Country (2017-2022)

    • Figure United States Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Canada Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Table Europe Cholera Vaccine (Oral Route) Consumption by Country (2017-2022)

    • Figure Germany Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure UK Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Spain Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure France Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Italy Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Finland Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Norway Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Poland Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Russia Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Table APAC Cholera Vaccine (Oral Route) Consumption by Country (2017-2022)

    • Figure China Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Japan Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure India Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Table South America Cholera Vaccine (Oral Route) Consumption by Country (2017-2022)

    • Figure Brazil Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Chile Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Peru Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Table GCC Cholera Vaccine (Oral Route) Consumption by Country (2017-2022)

    • Figure Bahrain Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Oman Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Table Africa Cholera Vaccine (Oral Route) Consumption by Country (2017-2022)

    • Figure Nigeria Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Table Oceania Cholera Vaccine (Oral Route) Consumption by Country (2017-2022)

    • Figure Australia Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Cholera Vaccine (Oral Route) Consumption and Growth Rate (2017-2022)

    • Table Valneva Company Details

    • Table Valneva Cholera Vaccine (Oral Route) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valneva Cholera Vaccine (Oral Route) Main Business and Markets Served

    • Table Valneva Cholera Vaccine (Oral Route) Product Portfolio

    • Table EuBiologics Company Details

    • Table EuBiologics Cholera Vaccine (Oral Route) Sales, Price, Value and Gross Profit (2017-2022)

    • Table EuBiologics Cholera Vaccine (Oral Route) Main Business and Markets Served

    • Table EuBiologics Cholera Vaccine (Oral Route) Product Portfolio

    • Table PaxVax Company Details

    • Table PaxVax Cholera Vaccine (Oral Route) Sales, Price, Value and Gross Profit (2017-2022)

    • Table PaxVax Cholera Vaccine (Oral Route) Main Business and Markets Served

    • Table PaxVax Cholera Vaccine (Oral Route) Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Cholera Vaccine (Oral Route) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Cholera Vaccine (Oral Route) Main Business and Markets Served

    • Table Sanofi Cholera Vaccine (Oral Route) Product Portfolio

    • Figure Global Shanchol Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dukoral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaxchora Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research & Academic Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cholera Vaccine (Oral Route) Consumption Forecast by Country (2017-2022)

    • Table North America Cholera Vaccine (Oral Route) Consumption Forecast by Country (2017-2022)

    • Figure United States Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cholera Vaccine (Oral Route) Consumption Forecast by Country (2017-2022)

    • Figure Germany Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Cholera Vaccine (Oral Route) Consumption Forecast by Country (2017-2022)

    • Figure China Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Cholera Vaccine (Oral Route) Consumption Forecast by Country (2017-2022)

    • Figure Brazil Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Cholera Vaccine (Oral Route) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Cholera Vaccine (Oral Route) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Cholera Vaccine (Oral Route) Consumption Forecast by Country (2022-2028)

    • Figure Australia Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Cholera Vaccine (Oral Route) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US